Tsubasa Yokota
Miyazaki, 8891692, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Metformin ameliorates the severity of experimental Alport syndrome.
Journal: Scientific reports
Published: October 01, 2020
Measurement of methotrexate in human cerebrospinal fluid using a chemiluminescence immunoassay intended for serum and plasma matrices.
Journal: Journal of clinical laboratory analysis
Published: August 19, 2020
Role of FK506 Binding Protein on Tacrolimus Distribution in Red Blood Cells.
Journal: Pharmaceutical research
Published: February 10, 2020
Anti-proliferative Activities of Some Bivalent Symmetrical 5-Substituted Hydantoin Derivatives towards Human Brain Glioma U251 Cells (U251) and Human Carcinoma Cells (KB3-1).
Journal: Biological & pharmaceutical bulletin
Published: November 06, 2019
Anti-proliferative Activities towards Human Brain Glioma U251 Cells and Human Carcinoma Cells (KB3-1) of Some Twin-Drug Type Bivalent C2-Symmetrical Phenylboronic Acid Derivatives.
Journal: Biological & pharmaceutical bulletin
Published: May 08, 2019
A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome.
Journal: Cell chemical biology
Published: October 11, 2017
STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 15, 2016
Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
Journal: Clinical and experimental nephrology
Published: November 28, 2016
Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 01, 2015
Last Updated: 09/26/2026